Early research (Phase 1)Ended earlyNCT05904236What this trial is testingSafety and Tolerability of Intravenous Administration of ICVB-1042Who this might be right forPatients With Advanced Solid Tumors IconOVir Bio 17
Early research (Phase 1)Ended earlyNCT05573035What this trial is testingInvestigate LYL845 in Adults With Solid TumorsWho this might be right forMelanomaNon-small Cell Lung CancerColorectal Cancer Lyell Immunopharma, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT07189871What this trial is testing177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid TumorsWho this might be right forCastration-Resistant Prostate Cancer (CRPC)Colorectal CancerNSCLC (Non-small Cell Lung Cancer)+7 more Radiopharm Theranostics, Ltd 61
Early research (Phase 1)UnknownNCT04739293What this trial is testingStudy of ON 123300 in Patients With Advanced CancerWho this might be right forSolid Tumors, Adult Traws Pharma, Inc. 36
Early research (Phase 1)Looking for participantsNCT06487624What this trial is testingAn Engineered Sirpα Fused to Anti-Pd-L1 And Tgf-β Fusion Protein (HCB301) in Subjects With Selected Advanced TumorsWho this might be right forAdvanced Solid TumorRefractory Hodgkin Lymphoma FBD Biologics Limited 50
Early research (Phase 1)Looking for participantsNCT06730659What this trial is testingA Clinical Study of CHT101 in CD70-Positive Advanced Solid TumorsWho this might be right forRelapsed / Refractory Solid Tumor Tianjin Medical University Cancer Institute and Hospital 36
Testing effectiveness (Phase 2)Study completedNCT03526250What this trial is testingPalbociclib in Treating Patients With Relapsed or Refractory Rb Positive Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating Alterations in Cell Cycle Genes (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Ewing Sarcoma+29 more National Cancer Institute (NCI) 23
Early research (Phase 1)Looking for participantsNCT05768932What this trial is testingBAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid LeukemiaWho this might be right forAdvanced Solid TumorTNBC - Triple-Negative Breast CancerGastric Cancer+1 more SillaJen, Inc. 260
Early research (Phase 1)Study completedNCT00635778What this trial is testingA Dose-finding Study of Dalotuzumab in Subjects With Advanced Solid Tumors (MK-0646-002)Who this might be right forAdvanced Solid Tumors Merck Sharp & Dohme LLC 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT03210714What this trial is testingErdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)Who this might be right forAdvanced Malignant Solid NeoplasmRecurrent Childhood EpendymomaRecurrent Childhood Malignant Germ Cell Tumor+29 more National Cancer Institute (NCI) 20
Testing effectiveness (Phase 2)Study completedNCT01588821What this trial is testingCabozantinib in Advanced Solid MalignanciesWho this might be right forLung CancerSolid Tumor (Not Breast or Prostate Cancers) Massachusetts General Hospital 37
Early research (Phase 1)Looking for participantsNCT06484816What this trial is testingTGRX-1942 Chinese Phase I for Advanced Solid Tumor And/or Relapsed/Refractory Hematologic MalignanciesWho this might be right forNon Small Cell Lung CancerAdvanced Solid TumorHematologic Malignancy Shenzhen TargetRx Co., Ltd. 90
Early research (Phase 1)Looking for participantsNCT05302037What this trial is testingAllogeneic NKG2DL-targeting CAR γδ T Cells (CTM-N2D) in Advanced Cancers (ANGELICA)Who this might be right forCancerMalignancyRefractory Cancer+1 more CytoMed Therapeutics Pte Ltd 12
Testing effectiveness (Phase 2)UnknownNCT04458389What this trial is testingTY101 for Locally Advanced /Metastatic Solid Tumors and Relapsed or Refractory LymphomasWho this might be right forLocally Advanced /Metastatic Solid TumorsRelapsed or Refractory Lymphomas Tayu Huaxia Biotech Medical Group Co., Ltd. 268
Testing effectiveness (Phase 2)Active Not RecruitingNCT05662397What this trial is testingHST-1011 Given as Monotherapy and in Combination With an Anti-PD1 AntibodyWho this might be right forSolid Tumor, AdultRelapsed CancerRefractory Cancer HotSpot Therapeutics, Inc 77
Early research (Phase 1)Study completedNCT01596140What this trial is testingVemurafenib in Combination With Everolimus or Temsirolimus With Advanced CancerWho this might be right forAdvanced CancerSolid Tumor M.D. Anderson Cancer Center 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT04243499What this trial is testingFirst-in-Human Study of ICT01 in Patients With Advanced CancerWho this might be right forSolid Tumor, AdultHematopoietic/Lymphoid Cancer ImCheck Therapeutics, an Ipsen company 293
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Not applicableLooking for participantsNCT06404528What this trial is testingLow-dose Chemotherapy Under Hypoglycaemia for the Treatment of Relapsed Refractory Advanced Solid TumoursWho this might be right forSolid Tumors, Adult Wuxi People's Hospital 300
Testing effectiveness (Phase 2)Active Not RecruitingNCT02650401What this trial is testingStudy Of Entrectinib (Rxdx-101) in Children and Adolescents With Locally Advanced Or Metastatic Solid Or Primary CNS Tumors And/Or Who Have No Satisfactory Treatment OptionsWho this might be right forSolid TumorsCNS Tumors Hoffmann-La Roche 69